Morgan Stanley’s Braveheart Bio BRVE Stock Holding History
Bought
Maintained
Sold
Other funds holding BRVE
Morgan Stanley's BRVE Position: Q3 2026 in Review
Morgan Stanley opened a new position in Braveheart Bio (BRVE) in Q3 2026: 7,658 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #6118 among its holdings.
64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.
- Morgan Stanley held 7,658 shares of Braveheart Bio worth $155K as of Q3 2026.
- Braveheart Bio was a new Morgan Stanley position in Q3 2026.
- Braveheart Bio made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #6118 holding.
- 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.